For Brooklyn patients, the best match may be in Brooklyn or a short trip into Manhattan. Insurance network and authorization can matter more than borough lines.
FDA labeling for treatment-resistant depression uses twice-weekly dosing during weeks 1 to 4, then less frequent treatment. Each dose is administered under healthcare supervision with at least two hours of monitoring, so repeated travel time matters.
Source: FDA Spravato prescribing information
A farther in-network center may cost less than a closer out-of-network option. Ketamine Compass therefore ranks insurance, budget, treatment type, location, and clinical support together.
No. Spravato must be administered under healthcare supervision in a certified treatment setting.
For treatment-resistant depression, FDA labeling describes twice-weekly dosing during weeks 1 to 4, followed by less frequent dosing based on the treatment plan.
Not necessarily. A nearby Manhattan clinic may be a better match if it is in network, easier to authorize, or better aligned with your care preferences.
Answer 13 questions about insurance, budget, treatment preference, location, and desired clinical support. Ketamine Compass will rank options from our provider dataset.
Show my matches